Nanoparticle dispersions for pulmonary delivery of antiviral drugs to combat COVID-19
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: NS/C000001/1
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$20,040.59Funder
UK Research and Innovation (UKRI)Principal Investigator
Prof. Steve Rannard, Dr. Tom McDonaldResearch Location
United KingdomLead Research Institution
University of LiverpoolResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Limited ventilator availability is currently a global issue. This project aims to provide an alternative to ventilation by building upon ongoing solid drug nanoparticle formulation research of antivirals to develop therapeutic nebulised medicine options for COVID-19 treatment